NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,269,441 | +0.1% | 22,280 | -0.9% | 1.80% | +6.0% |
| Q2 2023 | $2,267,650 | +6.5% | 22,472 | -2.9% | 1.69% | +0.4% |
| Q1 2023 | $2,129,800 | +1.5% | 23,150 | +0.1% | 1.69% | -3.4% |
| Q4 2022 | $2,097,900 | +11.5% | 23,125 | -0.3% | 1.75% | +8.0% |
| Q3 2022 | $1,882,000 | -99.9% | 23,195 | +1.2% | 1.62% | +6.2% |
| Q2 2022 | $1,937,850,000 | -4.9% | 22,925 | -1.3% | 1.52% | +22.6% |
| Q1 2022 | $2,037,291,000 | -0.6% | 23,217 | -1.0% | 1.24% | +3.3% |
| Q4 2021 | $2,050,296,000 | +11.6% | 23,440 | +4.3% | 1.20% | +0.3% |
| Q3 2021 | $1,837,596,000 | -6.6% | 22,470 | +4.2% | 1.20% | -3.4% |
| Q2 2021 | $1,968,046,000 | +6.4% | 21,570 | -0.3% | 1.24% | +3.1% |
| Q1 2021 | $1,849,787,000 | -7.8% | 21,640 | +1.9% | 1.20% | -18.2% |
| Q4 2020 | $2,005,693,000 | +10.3% | 21,240 | +1.6% | 1.47% | -4.6% |
| Q3 2020 | $1,817,898,000 | -0.0% | 20,905 | +0.4% | 1.54% | -10.2% |
| Q2 2020 | $1,818,418,000 | +5.7% | 20,820 | -0.2% | 1.72% | -9.5% |
| Q1 2020 | $1,720,731,000 | -14.7% | 20,870 | -2.1% | 1.90% | +22.9% |
| Q4 2019 | $2,018,317,000 | +3.4% | 21,315 | -5.1% | 1.54% | +2.5% |
| Q3 2019 | $1,951,340,000 | -2.6% | 22,455 | +2.3% | 1.51% | -11.4% |
| Q2 2019 | $2,003,341,000 | -4.0% | 21,940 | +1.1% | 1.70% | -9.1% |
| Q1 2019 | $2,086,718,000 | +10.5% | 21,705 | -1.4% | 1.87% | -2.0% |
| Q4 2018 | $1,888,249,000 | -1.0% | 22,005 | -0.6% | 1.91% | +18.3% |
| Q3 2018 | $1,908,013,000 | +12.4% | 22,145 | -1.4% | 1.61% | +6.5% |
| Q2 2018 | $1,697,383,000 | -20.0% | 22,470 | -14.4% | 1.52% | -9.3% |
| Q1 2018 | $2,122,313,000 | -1.4% | 26,250 | +2.4% | 1.67% | -2.1% |
| Q4 2017 | $2,151,475,000 | -1.7% | 25,625 | +0.5% | 1.71% | -6.5% |
| Q3 2017 | $2,188,745,000 | +2.8% | 25,495 | -0.1% | 1.82% | +0.7% |
| Q2 2017 | $2,129,319,000 | +11.8% | 25,510 | -0.6% | 1.81% | +8.4% |
| Q1 2017 | $1,905,396,000 | -1.0% | 25,655 | -2.9% | 1.67% | +2.0% |
| Q4 2016 | $1,924,068,000 | +1.9% | 26,415 | +15.4% | 1.64% | -9.8% |
| Q2 2016 | $1,888,653,000 | – | 22,890 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |